Background/Aims: Polycystic ovary syndrome (PCOS), characterized by female infertility and metabolic abnormalities, is one of the most common endocrine disorders. The etiology of PCOS remains unknown. The comprehensive analysis of protein alterations in PCOS patients is meaningful for identifying diagnostic biomarkers of PCOS. Here, we explored the clinical value of serum proteins as novel biomarkers to detect PCOS with low progesterone level. Methods: A total of 43 patients with PCOS and 30 healthy women were enrolled. Protein array was used to detect the variations of serum proteins between PCOS patients and healthy women. The level of five serum proteins was further confirmed by ELISA and western blot. The human ovarian granulosa cells (KGN) was cultured to examine the underlying mechanism of PCOS. CCK8 assay and western blot were carried out to evaluate the alterations in proliferative ability, TUNEL assay and DAPI staining to detect the apoptosis of KGN cells. Results: Among the 507 proteins, we identified 76 differentially expressed serum proteins (≧1.5 fold), with 40 elevated and 36 decreased proteins. Moreover, 47 proteins were newly reported in PCOS. The alterations in the five significantly decreased proteins (EREG, inhibin βA, IDE, PDGF-D and KNG1) were further confirmed by ELISA and western blot. The level of these proteins were directly associated with the low progesterone, and the expression could be upregulated by progesterone. EREG and inhibin βA also promoted the proliferation and inhibited the apoptosis of ovarian granulosa cells. Conclusion: The study highlights that serum proteins are differentially expressed in PCOS patients and healthy women, and EREG and inhibin βA levels are upregulated by progesterone, which are correlated with ovarian functions. The study suggests that EREG and inhibin βA may be applied as novel potential biomarkers for PCOS with low progesterone level.
Introduction
Polycystic ovary syndrome (PCOS) is a complicated endocrine abnormality in women with childbearing age that is characterized by female infertility and metabolic aberrations [1] . Its incidence has increased yearly in reproductive age women, which is reported to be as high as 5-10% [2] . At present, PCOS is predominantly diagnosed by ultrasound scans of ovaries, clinical manifestations, and measurement of hormones in serum [3] . The etiology of PCOS is complex and remains uncertain. Numerous studies have shown that many factors are associated with PCOS. Therefore, it is imperative to discover diagnostic biomarkers to provide auxiliary indexes for PCOS detection.
As the main mediators, hormones are required for follicle maturation, ovulation, embryo development, and the establishment of endometrial receptivity [4, 5] . Hormones that regulate ovarian functions include luteinizing hormone (LH), follicle stimulating hormone (FSH), progesterone, estrogen and androgen. Progesterone is a steroid hormone produced by ovarian granulosa cells under the regulation of hypothalamus gonadotropin and pituitary LH [6] . LH promotes the formation of the corpus luteum after ovulation and stimulates the synthesis of progesterone [7] . In addition, progesterone can regulate ovarian functions and affect downstream target organs, such as uterus, oviduct and placenta [8] . Patients of PCOS are unable to form corpus luteum and generate low level of progesterone, thus leading to the dysfunction in ovulation [9] . Progesterone is also an essential pregnancy hormone in maintaining embryo development and endometrial receptivity [10] . Low dose progesterone has been reported to treat patients with infertility or possible abortion caused by ovulation dysfunction [11] . In pregnant patients with PCOS, appropriate progesterone treatment could reduce the occurrence of miscarriage, preeclampsia and premature delivery [12] . Therefore, the measurement of altered proteins caused by abnormal progesterone is indispensable for understanding the pathogenesis, and provides biomarkers for PCOS detection and treatment.
A variety of pathological processes are involved in the pathogenesis of PCOS, such as chronic inflammation, dysfunction of extracellular matrix degradation and proliferation or apoptosis of granulosa cells. The inhibition of granulosa cells proliferation leads to the impairment of follicle development, as well as follicular atresia and even ovulation disorder [13] . Furthermore, this process is also accompanied by changes in many molecules, like cytokines, growth factors and adhesion molecules. Recently, cytokines have emerged as key contributors to human reproductive activities, and participate in the modulation of ovarian functions [14] . Xia et al. found that IL-1β was increased in serum, and positively correlated with the incidence of PCOS [15] . Gallinelli et al. reported that IL-12 was decreased in the follicular fluid of PCOS patients compared to controls, and the increased IL-13 was associated with the occurrence and development of PCOS [16] . Moreover, growth factors and their receptors are also involved in regulating reproductive processes of the ovary. Epiregulin (EREG), a member of the EGF family, has been reported to promote oocyte maturation, ovulation and embryo implantation [17] . However, the role of EREG in PCOS has not yet been investigated. Inhibins belong to the superfamily of TGFβ, and express in the ovary, testis, placenta and adrenal gland. They are produced and secreted by ovarian granulosa cells [18] . Inhibin βA is one subunit of inhibin A, which is consist of an ɑ subunit dislphide linked to a βA subunit. Thus, the detection of inhibin βA in serum may reflect the development of ovarian granulosa cells and follicles.
The serological measurement for disease detection is widely used clinically, as it is a nontraumatic and noninvasive method. Meanwhile, serum samples are relatively easy to obtain. Serological testing for PCOS includes six hormones: LH, FSH, progesterone, estrogen, androgen and prolactin [19] . The combination with other serum biomarkers may increase the accuracy and specificity of PCOS detection. In our study, we collected serum samples from PCOS patients with low progesterone level, and screened differentially expressed proteins by using protein array. We found five decreased proteins: EREG, inhibin βA, insulysin (IDE), platelet-derived growth factor-D (PDGF-D) and kininogen (KNG1), and further explored the regulatory role of progesterone on the expression of these molecules, as well as the effects of EREG and inhibin βA on the proliferation and apoptosis of ovarian granulosa cells.
Materials and Methods

Ethics statement
The clinical serum samples obtained got the approval of Clinical Ethics Review Board of Shengjing Hospital of China Medical University. The research was in accordance with Institutional Review Board of Dalian Medical University.
Clinical samples
The serum samples from 43 patients diagnosed with PCOS and 30 healthy women paired by BMI and age were collected from Shengjing Hospital of China Medical University. The diagnosis criteria was followed Rotterdam criteria of 2003: oligoovulation; clinical evidence of hyperandrogenism and/or hyperandrogenemia; PCO morphology (12 or more with 2-9 mm follicles, or >10 ml in volume in at least one ovary); Moreover, the exclusion of related disorders including congenital adrenal hyperplasia, Cushing's syndrome and androgen-producing tumors. The healthy women were with regular menstrual cycles and normal hormone levels, without family history of endocrine abnormality or evidence of PCOS, excessive acne or hirsutism. No subjects had used pharmacological treatment. Informed consent was given to every patient.
Protein array
Protein array was purchased from RayBiotech (Arraystar, Rockville, USA). Total protein was extracted and the protein concentration was determined by BCA protein assay kit (KANGCHEN, Shanghai, China). The protein array membranes were blocked in blocking buffer for 30 min, and then incubated with samples at 4°C overnight. The samples were decanted and washed with washing buffer. After washing, the membranes were incubated with diluted biotin-conjugated antibodies for 1-2 h at room temperature. Then, the membranes were reacted with streptavidin-conjugated fluor, and scanned by a Axon GenePix laser scanner after washing thoroughly. The relative expression of proteins was made by comparing the signal intensities. Raw intensities were revised by background and normalized by median background signals. The intensities of signals were quantified by densitometry, and relative differences in expression levels of each sample were determined. Any ≧1.5 fold increase or ≦0.65 fold decrease in signal intensity for a single analyte between samples may be considered a measurable and significant difference in expression according to our experimental condition, which provided that both sets of signals were well above background (mean background+2 standard deviations, accuracy≈95% ). Thus, for protein quantitation from protein array, the ratios of samples were weighted and normalized to control samples. For quantitative fold changes, we set a fold change ≧1.5 as cutoff for differentially expressed proteins selection.
Cell culture
A human ovarian granulosa cell line (KGN) was obtained from RIKEN (Tokyo, Japan). The KGN cells were undifferentiated which maintained the physiological characteristics of human ovarian granulosa cells. KGN cells were cultured in DMEM/F12 medium (Invitrogen, Grand Island, NY, USA) with 10% fetal bovine serum, 100 U/mL penicillin-streptomycin and grown at 37°C, 5% CO 2 atmosphere. Western blot Cells were lysed on ice for 20 min in RIPA lysis buffer containing protease inhibitor. The protein concentration was detected, and the extract was separated in a 12% SDS-PAGE gel and transferred onto nitrocellulose membranes (Millipore, Billerica, MA, USA). After blocking with 5% non-fat dry milk, the membranes were incubated with primary antibodies at 4°C overnight with anti-EREG (1:500, Abcam, Cambridge, UK), anti-inhibin βA (1:500, Abcam, Cambridge, UK), anti-PDGF-D (1:500, Proteintech Group, Wuhan, China), anti-IDE (1:1000, Proteintech Group, Wuhan, China), anti-KNG1 (1:500, Proteintech Group, Wuhan, China), anti-PCNA (1:2000, Proteintech Group, Wuhan, China), anti-Bcl-2 (1:2000, Proteintech Group, Wuhan, China), anti-Bax (1:2000, Proteintech Group, Wuhan, China), anti-caspase 8 (1:500, Proteintech Group, Wuhan, China), anti-caspase 9 (1:500, Proteintech Group, Wuhan, China) and anti-GAPDH (1:2000, Proteintech Group, Wuhan, China). Washing with TBST for three times, membranes were incubated with horse-radish peroxidase-conjugated goat anti-rabbit antibody (1:2000, ZSGB-BIO, Beijing, China) for 45 min. GAPDH and Coomassie brilliant blue (CBB) was used as an equal loading control. The signals were visualized with enhanced chemiluminescence system, and the protein bands were analyzed with Image J software (NIH, Bethesda, MD, USA).
Cell proliferation assay
Cells were seeded in 96-well plate with a density of 3000 cells per well, and incubated with different concentrations of EREG (0, 10, 100 µg/ml, PeproTech, NJ, USA), inhibin βA (0, 10, 100 µg/ml, Abcam, Cambridge, UK) or their specific antibodies (anti-EREG: 1:200, Abcam, Cambridge, UK; anti-inhibin βA: 1:100, Abcam, Cambridge, UK), respectively. The effects of EREG and inhibin βA on cell proliferation were determined with Cell Counting Kit 8 (CCK8, Beyotime Biotechnology, Beijing, China) according to the protocols. CCK8 solution was added to the medium and incubated for 2 h at 37°C. The absorbance at 450 nm was detected, and the data were recorded and analyzed. Triplicate independent experiments were performed.
Immunofluorescent staining KGN cells were cultured on glass coverslip and fixed in 4% para-formaldehyde for 20 min at room temperature, followed with permeabilized in 0.1% Triton X-100 for 10 min. The primary antibody of PCNA (1:50) was used at 4°C overnight after blocking in 3% bovine serum for 1 h. After washing with PBS for three times, cells were incubated with TRITC-conjugated goat anti-rabbit IgG (1:100, Sigma-Aldrich, St.Louis, MO, USA) for 1 h at room temperature. The nucleus was stained with DAPI (1:1000, Beyotime Biotechnology, Beijing, China) in dark for 5 min. Images were taken with a fluorescence microscope (Olympus, Tokyo, Japan), and the representative pictures were shown.
Cell apoptosis assay
Morphological evaluation of cell apoptosis was carried out by using DAPI staining. Cells grown on the coverslip after treatment were fixed with 4% para-formaldehyde for 20 min at room temperature, and incubated with 0.1% Triton X-100 for 10 min. After washing, cells were stained with DAPI for 5 min in dark. Images were acquired under a fluorescence microscope.
Statistical analysis
The results obtained from at least three independent experiments were expressed as mean ± S.E.M. Statistical analysis was carried out using the Prism version 6.0 program (GraphPad). Differences were analyzed with Student's t-test for comparison differences between groups by using SPSS 17.0 (SPSS, Inc, Chicago, IL). Spearman's correlation analysis was used to evaluate the relationship between progesterone and EREG, inhibin βA, IDE, PDGF-D and KNG1 in serum of patients with PCOS. P-value<0.05 was considered as statistical significance.
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Results
Differential expression of proteins in serum of PCOS patients
To determine the alterations of serum proteins, protein array was used for screening. As shown, 507 proteins in serum were detected. Expression level of 76 proteins (Fig. 1) were changed over 1.5 times in serum of PCOS patients compared to healthy controls, and 47 kinds of proteins were newly reported. The results showed that there were 40 kinds of proteins with elevated level among the 507 proteins ( (Table 2 ). We first found novel differentially expressed proteins (EREG, IDE, PDGF-D and KNG1) in serum of PCOS patients. The above results provide evidence that some serum proteins in PCOS patients are greatly altered, which may be act as pathogenesis factors of PCOS, and applied as potential biomarkers for PCOS detection.
Analysis of EREG, inhibin βA, IDE, PDGF-D and KNG1 levels in serum of PCOS patients
Based on the data from above protein array, we selected five significantly decreased protein molecules, including EREG, inhibin βA, IDE, PDGF-D and KNG1, to further confirm the alterations in more serum samples of PCOS patients by ELISA and western blot. The serum samples of PCOS (43 cases) with low progesterone level and those from healthy women (30 cases) in childbearing age with normal progesterone level were collected. ELISA assay results showed that in serum of PCOS patients, EREG ( Fig. 2A), inhibin βA (Fig. 2B), IDE (Fig. 2C) , PDGF-D (Fig. 2D) and KNG1 (Fig.  2E ) levels were lower as compared to the levels in healthy controls, which were in accordance with the data of protein array. Furthermore, spearman's correlation analysis revealed that the decreased level of the proteins, EREG (Fig. 2F), inhibin βA (Fig. 2G), IDE (Fig. 2H) , PDGF-D (Fig. 2I) and KNG1 (Fig. 2J) , were directly related to the low progesterone value, with the (Fig. 2L) , 10 -5 and 10 -4 M). The results showed that level of EREG (Fig. 3A) , inhibin βA (Fig. 3B) , IDE (Fig. 3C) , PDGF-D (Fig. 3D) and KNG1 (Fig. 3E) were increased with elevated progesterone concentrations, and the protein level detected by western blot presented similar changes (Fig. 3K) . Moreover, we found that the expression of EREG (Fig. 3F) , inhibin βA (Fig. 3G) , IDE (Fig. 3H) , PDGF-D (Fig. 3I) and KNG1 (Fig. 3J ) in culture medium were increased, as well as their protein level ( (Fig. 4A ). The addition of the specific EREG antibody alone inhibited cell proliferation, while EREG stimulation restored the proliferation capability to some extent (Fig. 4B) . Western blot analysis (Fig. 4C ) and immunofluorescent staining results (Fig. 4G) presented an increase of PCNA expression in EREG treated group, which was decreased in the EREG antibody blocking group. Similar results were found when we examined the effect of inhibin βA on the proliferation of ovarian granulosa cells (Fig. 4D, 4E, 4F and H). We also investigated the potential roles of EREG and inhibin βA in modulating the apoptosis ability of ovarian granulosa cells. The results of DAPI staining showed an increased number of apoptotic cells in the specific EREG (Fig. 4I ) and inhibin βA antibody blocking groups (Fig. 4J) ; whereas EREG and inhibin βA treatment groups presented no detectable changes compared to the control group. Corroboratively, western blot analysis of apoptosis-related proteins demonstrated that the anti-apoptotic protein Bcl-2 was upregulated, and the pro-apoptotic proteins Bax, caspase 8, and caspase 9 were downregulated after treating with EREG or inhibin βA. While blocking EREG and inhibin βA with their specific antibodies significantly recovered the levels of apoptosisrelated proteins. Cells treated with EREG and inhibin βA specific antibodies significantly downregulated the expression of Bcl-2 and upregulated the levels of Bax, caspase 8, and caspase 9 ( Fig. 4K and L) . These results demonstrate that EREG and inhibin βA promote the proliferation and inhibit the apoptosis of ovarian granulosa cells. 
Discussion
Understanding the general alterations of proteins is not only benefit for elucidating the pathogenesis mechanism of PCOS, but also facilitating for discovering the sensitive and specific biomarkers which are closely associated with diseases. Quantitative analysis of proteins in serum with protein array can supply valuable information for clinical practice, including accurate medical and individualized treatment, which is based on protein screening. Recently, Meltzer et al. examined 500 proteins via protein array in serum samples collected from rectal cancer, and found the expression of OPG was increased which was correlated with the survival of rectal cancer patients after chemotherapy [20] . Jiang et al. analyzed 174 serum proteins of ovarian cancer using protein array screening, and discovered a significant 
difference of five proteins: MSP-alpha, TIMP-4, PDGF-R alpha, OPG and CA125, which might be regarded as diagnostic biomarkers for ovarian cancer [21] . We, for the first time, compared 507 serum proteins in PCOS patients and healthy controls with protein array, and identified 76 differentially expressed proteins, including 40 increased proteins and 36 The detection of EREG, inhibin βA, IDE, PDGF-D and KNG1 in serum will provide novel and specific potential diagnostic biomarkers for PCOS with low progesterone level. EREG plays a prominent role in regulating the maturation of follicles and ovarian functions. However, the role of EREG in PCOS-induced infertility has not been characterized. We had demonstrated firstly that the serum level of EREG was decreased in PCOS patients, and progesterone upregulated the expression of EREG. EREG is expressed in ovarian granulosa cells [22] , as well as liver progenitor cells. It was reported that the serum level of EREG was increased in patients with liver injury, which promoted the proliferation and DNA synthesis of liver progenitor cells [23] . Moreover, EREG could accelerate the proliferation and differentiation of dental stem cells by activating the MEK/ERK and JNK signaling pathways [24] . Our results showed that the proliferation and apoptosis of ovarian granulosa cells were regulated by EREG. The proliferation ability of ovarian granulosa cells was accelerated with an increased concentration of EREG, and reduced by EREG specific antibody blocking. EREG upregulated the expression of anti-apoptosis protein Bcl-2, and downregulated the expression of pro-apoptosis proteins Bax, caspase 8 and caspase 9, which was reversed by EREG antibody. Therefore, our novel findings emphasize that EREG is upregulated by progesterone, and promotes the proliferation and inhibits the apoptosis of ovarian granulosa cells.
Inhibins, including inhibin A and inhibin B, is produced by ovarian granulosa cells and serves as an essential marker for the development of follicles [25] . Inhibin βA is one subunit of inhibin A. Tsigkou A et al. reported that women with PCOS had a higher serum concentration of total inhibin, but lower concentration of dimeric inhibin A than that in healthy control groups [26] . Dafopoulos et al. found that inhibin A was decreased in PCOS patients, and the secretion of inhibin A was sensitive to exogenous FSH [27] . To date, there was no report about the expression of inhibin βA in serum of PCOS patients, only total inhibin or dimeric inhibin A. Our screening results showed that the expression of inhibin βA differed between PCOS patients and healthy controls. Reduced inhibin βA may serve as a potential diagnostic biomarker for PCOS detection. In contrast, Yetim et al. reported that the dimeric inhibin A level in serum of PCOS patients was significantly higher than that in controls [28] . The reasons for the different expression of inhibin βA or dimeric inhibin A in patients with PCOS may be as follows. The serum samples from PCOS patients that we analyzed had low progesterone level, which might have caused the decreased level of inhibin βA in the present study. Further study was required to investigate the detailed mechanism underlying the decreased serum level of inhibin βA. We stimulated ovarian granulosa cells with progesterone to examine the functional connection between progesterone and inhibin βA, and found the expression of inhibin βA was increased, which supported that progesterone enhanced the production and secretion of inhibin βA in ovarian granulosa cells. Jiang L et al. reported that the ectopic expression of inhibin βA in diffuse large B-cell lymphoma (DLBCL) cell lines lead to decreased cell proliferation and increased spontaneous apoptosis, which functioned as a tumor suppressor in DLBCL [29] . In our study, inhibin βA promoted cell proliferation, but inhibin βA antibody blocking inhibited cell proliferation. DAPI staining and western blot analysis further showed that inhibin βA antibody blocking could increase the number of apoptotic cells, as well as apoptosis-related protein levels. Together, our studies suggest that inhibin βA stimulates the proliferation and suppresses the apoptosis of ovarian granulosa cells.
As a crucial upstream factor, progesterone has been found to modulate the physiological functions of the ovary via controlling the production and secretion of many molecules. The above results revealed that progesterone promoted the expression of EREG, inhibin βA, IDE, PDGF-D and KNG1 in ovarian granulosa cells. It had been reported that IDE might be a susceptible gene for PCOS [30] . However, the changes of IDE in serum of PCOS patients remained poorly defined. We first discovered that the serum level of IDE in PCOS patients was notably decreased, and progesterone promoted the expression of IDE in ovarian granulosa cells. These findings demonstrate that IDE may serve as a potential biomarker for the diagnosis of PCOS. The PDGF family members include PDGF-A, PDGF-B, PDGF-C, and [35] . Indeed, we observed that decreased KNG1 level in serum of PCOS patients, and progesterone promoted the expression of KNG1 in ovarian granulosa cells. Our data demonstrate that changes in serum proteins are related to progesterone in PCOS patients, and progesterone improves ovarian functions by upregulating EREG, inhibin βA, IDE, PDGF-D and KNG1 expression. The accumulated evidences show that PCOS is one of the major causes leading to infertility [1, [36] [37] . Based on the complexity of hormone disorders in PCOS patients, such as high estrogen, high androgen, or low progesterone, as well as the combination of the 2 or 3 of the hormones [38] , although the clinical treatment strategy now is mainly by anti-estrogen with clomiphene citrate to induce ovulation and anti-androgen with flutamide to alleviate hyperandrogenism, we propose that progesterone supplementation in combination with routine treatments may improve the therapeutic effect in PCOS patients, and prevent the occurrence of abortion and premature delivery, especially patients with low progesterone level. In summary, we analyzed the serum proteins of PCOS patients using protein array, and identified five markedly decreased proteins (EREG, inhibin βA, IDE, PDGF-D and KNG1), which were positively correlated with progesterone. Cytological studies found that progesterone upregulated the expression of these proteins. Furthermore, EREG and inhibin βA promoted the proliferation and inhibited the apoptosis of ovarian granulosa cells. Our observations suggest that EREG and inhibin βA may be potential serological biomarkers for the detection of PCOS.
